Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
about
KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma.Blocking interleukin-6 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity of human medulloblastoma cells.SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.A drug-repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6-thioguanine as an effective therapeutic agent for TPMT-low cancer cells
P2860
Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
@en
type
label
Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
@en
prefLabel
Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
@en
P2093
P2860
P1476
Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
@en
P2093
Chenglong Li
Jiayuh Lin
Xiaojuan Wu
P2860
P304
P356
10.1158/1535-7163.MCT-15-0921
P577
2016-08-17T00:00:00Z